Intellia Therapeutics Inc. (NTLA) Climbed 5.55% or 1.54 To Price $29.28 On Tuesday


Intellia Therapeutics Inc. (NTLA) climbed 5.55% or 1.54 to $29.28. It is nearly 535772 shares traded, which is 87.73% compare to the average total volume 610692. The market cap of NTLA is $1.26 billion. The year to date change is 34.52%. The 52 week price range is from $15.25 to $35.99. Price of NTLA have changed -0.57% during last week. It have changed -12.27% over last month, 13.97% over last 3 months, 11.23% over last 6 months and 65.61% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NTLA is 28.40. It is -3.01% below current price. The 200-day Moving Averages for NTLA is 24.33. It is -16.91% below current price. The 52-week High is 35.99. It is 22.92% from the current price. The 52-week Low is 15.25. It is -47.92% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NTLA is 9.22 on 2018-07-31. Short % to float is 15.76%. There are some statistics of NTLA. It is has market cap $1.26 billion. The share outstanding is 43.20 million. The average volume is 610692. The revenue is 7.32M. The percent of top 15 Institution holding is 89.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NTLA is -35.51%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NTLA is -27.41%.


Tags:

Share this post